Presentation TCT 2025 TCT 1023: Comparative Effectiveness of DES, DCB, and BMS for the Treatment of In-Stent Restenosis in Carotid Artery Stents: A Systematic Review and Meta-Analysis Presenter: Mehmet Cilingiroglu October 28, 2025
Presentation TCT 2025 Stent Failure Through the Ages: BMS, First-Generation DES, and Beyond Presenter: Gary S. Mintz October 28, 2025
Presentation TCT 2017 SENIOR: A Randomized Trial of a Bioabsorbable Polymer-Based Metallic DES vs a BMS With Short DAPT in Patients With Coronary Artery Disease Older Than 75 Years Presenter: Robert A. Harrington, Gregg W. Stone, Olivier Varenne November 01, 2017
Presentation TCT 2017 DEBATE-SFA: A Randomized Trial of a BMS With or Without Cilostazol vs a DES in Patients With Femoropopliteal Disease Presenter: David P. Faxon, Joseph A. Hill, Yusuke Miyashita October 31, 2017
Presentation TCT 2017 Emerging Thromboresistant BMS 2: Titanium-Nitride-Oxide Stents Presenter: Julinda Mehilli, Giulio G. Stefanini, Pim A.L. Tonino October 30, 2017
Presentation TCT 2017 Debate: How should SFA Disease be Treated? In most cases DCB (± BMS) Presenter: D. Christopher Metzger October 30, 2017
Presentation TCT 2017 Emerging Thromboresistant BMS 1: Cobra PzF Stents Presenter: Julinda Mehilli, Giulio G. Stefanini, Donald Cutlip October 30, 2017
Presentation TCT 2017 Should BMS Stay On the Shelf? Clinical and Global Perspectives on the Role Of BMS in 2017 Presenter: Julinda Mehilli, Giulio G. Stefanini, Raffaele Piccolo October 30, 2017
Presentation TCT 2017 The Alphabet of Peripheral Vascular Devices: BMS, DES, PTFE, BVS, and Future Scaffolds Presenter: Michael Guiry, Julie Logan October 30, 2017
Presentation TCT 2016 The Alphabet Soup of SFA Scaffolds and Their Outcomes: BMS, VMI, DES, PTFE Presenter: Tony Das, Koen Deloose, Ehrin J. Armstrong October 31, 2016
Presentation TCT 2016 New Insights Into the Mechanisms and Patterns of in-stent Restenosis in BMS and DES Evaluated By IVUS and OCT (With Case Examples) Presenter: Fernando Alfonso, Stephan Windecker, Akiko Maehara October 30, 2016
Presentation TCT 2016 Great Debate 2: Implications from NORSTENT: BMS Are Yesterday's History! Presenter: Manel Sabate, Robert-Jan van Geuns, Sunil V. Rao October 30, 2016
Presentation TCT 2016 Great Debate 2: Implications from NORSTENT: BMS will Continue to Play an Important Role! Presenter: Manel Sabate, Robert-Jan van Geuns, Eric R. Bates October 30, 2016
Presentation TCT 2015 LEADERS FREE: A Prospective, Double-blind Randomized Trial of a Polymer-Free Biolimus-Eluting Stent vs BMS in Patients With Coronary Artery Disease at High Risk for Bleeding Presenter: Philip M. Urban October 14, 2015
Presentation TCT 2015 DCBs Plus Adjunctive BMS Use: Current Use, Rationale, and Pitfalls Presenter: Krishna J. Rocha-Singh, Andrej Schmidt October 12, 2015
Presentation TCT 2015 In Which Patients (if Any) Should BMS Be Used in 2015? Evidence and Common Sense Presenter: John A. Bittl, E. Magnus Ohman, Marco Valgimigli October 11, 2015
Presentation TCT 2014 A Rational Approach for Stent Selection in ACS: BMS vs Metallic DES vs BRS Presenter: Christopher B. Granger, Marco Valgimigli, David A. Cox, Huay Cheem Tan September 16, 2014
Presentation TCT 2014 The Inexorable Accumulation of Late Events After Metallic BMS and DES: Mechanisms and Clinical Data Presenter: Dean J. Kereiakes, Renu Virmani, Christian M. Spaulding, Stephen G. Ellis September 16, 2014
Presentation TCT 2014 DCB and the Use of Ancillary Devices I: BMSDCB Interactions Provisional Versus Primary Use? Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri, Francesco Liistro September 15, 2014
Presentation TCT 2014 Clinical Perspectives: When Should BMS Be Used Preferentially Over Current-Generation DES? STEMI? Prior to Surgery? Elsewhere? Presenter: Philip M. Urban, Marco Valgimigli, Christian M. Spaulding, Anthony H. Gershlick September 14, 2014